https://doi.org/10.31288/oftalmolzh201537681

Protective effect of quercetin and lypoate of functional groups on proteins in retina with experimental diabetes

NV Pasechnikova1, OA Moroz 2, 

1 SI «Filatov Institute of Eye Diseases and Tissue Therapy of NAMS of Ukraine»; Odessa (Ukraine)

2 Zakarpatsky Regional Clinical Hospital named after A. Nowak; Uzhgorod (Ukraine)

Introduction. Relevance of the work is to study of influence of quercetin and lypoate on treatment with experimental diabetes.

Purpose. To study the effect of quercetin and lipoate on thiol groups of proteins in experimental diabetes.

Methods. Studies were conducted on white rats. Experimental animals were divided into four groups: first — control group (14 rats), the second — experimental group (14 rats), animals with diabetes, without the use of drugs, the third — the experimental group (12 rats), animals with diabetes, and the use of lipoic acid, the fourth — the experimental group (15 rats), animals with diabetes and the use of quercetin. In retinas homogenates produced determination of thiol groups of proteins.

Results. Application of preparations of lipoic acid and quercetin prevents the fall-off of level of thiol groups of proteins of retina. In the mechanism of this effect undoubtedly an important role is played by their antioxidant properties.

Conclusion. 1. It is set that at development of streptozotocin diabetes the making progress decline of thiol groups of proteins of retina and increase of disulfide bridges are marked, i.e. oxidization of sulfhydryl groups. 2. Application of lipoic acid and quercetin prevents the considerable decline of level of thiol groups of proteins of retina for animals with streptozotocin diabetes, here marked the most expressed effect for animals in a two-month period of development of experimental diabetes after application of lipoic acid, when differences in the level of thiols were statistically meaningful.

Key words: streptozotocin diabetes, retina, experiment, thiol groups of proteins

References

Aleksandrovskii AYa. Molecular mechanisms of the development of diabetic complications. Biokhimiia. 1998;63(11): 1470–1479. In Russian. 

Balabolkin MI. The role of protein glycation, oxidative stress in the pathogenesis of vascular complications in diabetes. Russ. Med. Zhurnal. 2006; 2:34–39. In Russian.

Verevkina IV, Tochilkin AL, Popova NA. Colorimetric method for determination of SH-groups and SS-links in proteins using 5.5-dithiobis (2-nitrobenzoic) acid. Modern methods in biochemistry. M.: Meditsina; 1997. 223–231. 

Veselovskaia ZF. Diabetes complications of the eye. Praktychna angiologiia. 2006;3:56–8. In Russian. 

Leus NF. Metabolic mechanisms of development and prospects of medical treatment of diabetic retinopathy. Oftalmol Zh. 2003;5:75–80. In Russian. 

Leus NF, Oleinik TV, Kolomiichuk SG. Effect of vitamin B1 preparations (cocarboxylase and benfotiamine) on biophysical and metabolic processes in the retina and plasma albino rats with streptozotocin diabetes. Oftalmol Zh. 2007;2:70–75. In Russian. 

Nasledov A. SPSS computer data analysis in psychology and social sciences. SPb.: Piter; 2005. 416 p. 

Nedzvetskaia OV. Modern trends in the treatment of diabetic retinopathy. Mezhdunar. Med. Zhurnal. 2000;3:56–58. In Russian. 

New methods of biochemical analysis. Izd. Leningrad. Universiteta;1991. 395 p.

Poltorak VV, Blokh KO, Malashenko AM. «Experimental modeling of diabetes to study the specific effect of new anti-diabetic agents. Guidelines», Kharkov; 1991. 19 p. 

Tsiselskii Yu. Effect of bioflavonoids on the biochemical indicators of blood serum of rats with experimental type 2 diabetes. Mezhd. Endokrinol. Zhurn. 2007;5:67–71/ In Russian. 

Aiello LP, Cahill MT, Wong JS. Systemic considerations in the management of diabetic retinopathy. Am. J. Ophthalmol. 2001;32:760–776.
Crossref

Bergamini CM, Gambetti S, Dondi A. Oxygen, reactive oxygen species and tissue damage. Cur.Pharm. Design. 2004;10 (14):1611–1626.
Crossref

Bergmeyer HU. Methoden der enzymatischen Analyse. Berlin; 1986. 2254–2265.

Bloomgarden ZT. Diabetic retinopathy and diabetic neuropathy. J. Diabetes Care. 2007;30 (3):760–765.
Crossref

Brownlee M. The pathobiology of diabetic complications (a unifying mechanism). J. Diabetes. 2005;54:1615–1625.
Crossref

Kowluru RA, Chan PS. Oxidative stress and diabetic retinopathy. Exp. Diabet. Res. 2007.12 p.
Crossref

Lorenzi M, Gerhardinger C. Early cellular and molecular changes induced by diabetes in the retina. Diabetologia. 2001; 44: 791–804.
Crossref

Pan H-Z, Zhang H, Chang D et al. The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br. J Ophthalmol. 2008;92:548–551.
Crossref

Reyk D M, Gillies MC, Davies MJ. The retina: oxidative stress and diabetes. Redox Rep. 2003;8 (4):187–192.

Speicher MA, Danis RP, Criswell M. Pharmacologic therapy for diabetic retinopathy. Expert Opion Emerg Drugs. 2003; 8 (1): 239–250.

Wilkinson-Berka J, Miller A. Update on the treatment of diabetic retinopathy. The Scientific World J. 2008; 8: 98–120.